H J Son1, K K Oh. 1. Department of Diagnostic Radiology, Yong Dong Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Abstract
OBJECTIVE: We evaluated mammographic changes to assess the effect of tamoxifen in breast cancer patients who had undergone surgery. MATERIALS AND METHODS: We reviewed the mammograms of 102 breast cancer patients treated with tamoxifen (20 mg per day); these patients were subgrouped into tamoxifen-only patients and patients treated with tamoxifen in combination with another therapy (chemotherapy, radiotherapy, or both). The control group was made up of 50 breast cancer patients who did not undergo tamoxifen therapy and 20 healthy women who had an age distribution and menstruation status similar to those of the breast cancer patients. Two radiologists evaluated parenchymal patterns on mammograms of the contralateral breast in the breast cancer patients and of the left breast in the healthy women. Parenchymal changes before and after surgery were also analyzed. RESULTS: Follow-up mammography showed decreased breast parenchyma in 59.8% of the tamoxifen group, 87.0% of the premenopausal tamoxifen-treated women, 36.0% of the nontamoxifen patients, and 10.0% of the healthy women. CONCLUSION: On follow-up mammography of breast cancer patients, breast parenchyma was shown to be decreased after tamoxifen therapy. Mammography can be a useful method for evaluating breast parenchymal changes after tamoxifen treatment.
OBJECTIVE: We evaluated mammographic changes to assess the effect of tamoxifen in breast cancerpatients who had undergone surgery. MATERIALS AND METHODS: We reviewed the mammograms of 102 breast cancerpatients treated with tamoxifen (20 mg per day); these patients were subgrouped into tamoxifen-only patients and patients treated with tamoxifen in combination with another therapy (chemotherapy, radiotherapy, or both). The control group was made up of 50 breast cancerpatients who did not undergo tamoxifen therapy and 20 healthy women who had an age distribution and menstruation status similar to those of the breast cancerpatients. Two radiologists evaluated parenchymal patterns on mammograms of the contralateral breast in the breast cancerpatients and of the left breast in the healthy women. Parenchymal changes before and after surgery were also analyzed. RESULTS: Follow-up mammography showed decreased breast parenchyma in 59.8% of the tamoxifen group, 87.0% of the premenopausal tamoxifen-treated women, 36.0% of the nontamoxifen patients, and 10.0% of the healthy women. CONCLUSION: On follow-up mammography of breast cancerpatients, breast parenchyma was shown to be decreased after tamoxifen therapy. Mammography can be a useful method for evaluating breast parenchymal changes after tamoxifen treatment.
Authors: Sarah J Nyante; Mark E Sherman; Ruth M Pfeiffer; Amy Berrington de Gonzalez; Louise A Brinton; Erin J Aiello Bowles; Robert N Hoover; Andrew Glass; Gretchen L Gierach Journal: J Natl Cancer Inst Date: 2015-02-06 Impact factor: 13.506
Authors: Natalie J Engmann; Christopher G Scott; Matthew R Jensen; Lin Ma; Kathleen R Brandt; Amir Pasha Mahmoudzadeh; Serghei Malkov; Dana H Whaley; Carrie B Hruska; Fang Fang Wu; Stacey J Winham; Diana L Miglioretti; Aaron D Norman; John J Heine; John Shepherd; V Shane Pankratz; Celine M Vachon; Karla Kerlikowske Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-02-01 Impact factor: 4.254
Authors: Jingmei Li; Keith Humphreys; Louise Eriksson; Gustaf Edgren; Kamila Czene; Per Hall Journal: J Clin Oncol Date: 2013-04-22 Impact factor: 44.544
Authors: Celine M Vachon; Vera J Suman; Kathleen R Brandt; Matthew L Kosel; Aman U Buzdar; Janet E Olson; Fang-Fang Wu; Lynn M Flickinger; Giske Ursin; Catherine R Elliott; Lois Shepherd; Richard M Weinshilboum; Paul E Goss; James N Ingle Journal: Clin Cancer Res Date: 2013-03-06 Impact factor: 12.531
Authors: Sarah J Nyante; Mark E Sherman; Ruth M Pfeiffer; Amy Berrington de Gonzalez; Louise A Brinton; Erin J Aiello Bowles; Robert N Hoover; Andrew Glass; Gretchen L Gierach Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-11-06 Impact factor: 4.254